Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.85M Buy
23,708
+448
+2% +$51.7K 0.08% 228
2025
Q4
$2.45M Buy
23,260
+8,980
+63% +$843K 0.07% 233
2025
Q3
$1.2M Sell
14,280
-118
-0.8% -$9.72K 0.08% 209
2025
Q2
$1.14M Buy
14,398
+325
+2% +$25.8K 0.07% 213
2025
Q1
$1.26M Sell
14,073
-827
-6% -$77.2K 0.1% 178
2024
Q4
$1.48M Sell
14,900
-767
-5% -$79.1K 0.1% 174
2024
Q3
$1.78M Buy
15,667
+422
+3% +$50.1K 0.12% 165
2024
Q2
$1.89M Buy
15,245
+1,870
+14% +$241K 0.14% 142
2024
Q1
$1.76M Sell
13,375
-4,174
-24% -$514K 0.15% 134
2023
Q4
$1.91M Sell
17,549
-2,654
-13% -$275K 0.14% 144
2023
Q3
$2.16M Buy
+20,203
New +$2.18M 0.16% 130
2022
Q4
Sell
-3,208
Closed -$302K 238
2022
Q3
$302K Buy
+3,208
New +$286K 0.04% 223

Other funds holding MRK

WCG Wealth Advisors's MRK Position: Q1 2026 in Review

WCG Wealth Advisors increased its Merck (MRK) stake by 1.9% in Q1 2026, buying an estimated $51.7K and bringing the position to 23,708 shares worth $2.85M. The position accounts for 0.08% of the portfolio, ranked #228.

WCG Wealth Advisors first reported a position in MRK in Q3 2022 and has held it in 12 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • WCG Wealth Advisors held 23,708 shares of Merck worth $2.85M as of Q1 2026.
  • WCG Wealth Advisors bought 448 Merck shares in Q1 2026, an estimated $51.7K.
  • Merck made up 0.08% of WCG Wealth Advisors's portfolio in Q1 2026, its #228 holding.
  • WCG Wealth Advisors first reported a position in Merck in Q3 2022 and has held it in 12 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on WCG Wealth Advisors's 13F filing for Q1 2026, filed 12 May 2026.